Literature DB >> 30515560

Economic Analysis of a Three-Arm RCT Exploring the Delivery of Intensive, Prophylactic Swallowing Therapy to Patients with Head and Neck Cancer During (Chemo)Radiotherapy.

Laurelie R Wall1,2, Sanjeewa Kularatna3, Elizabeth C Ward4,5, Bena Cartmill5,6, Anne J Hill4, Elizabeth Isenring7, Joshua Byrnes3, Sandro V Porceddu8,9.   

Abstract

Research advocates for the use of intensive, prophylactic swallowing therapy to help reduce the severity of dysphagia in patients receiving (chemo)radiotherapy ([C]RT) for head/neck cancer (HNC). Unfortunately, the intensity of this therapy, coupled with growing patient numbers and limited clinical resources, provides challenges to many international cancer facilities. Telepractice has been proposed as a potential method to provide patients with greater support in home-practice, whilst minimising burden to the health service. This study investigated the clinical and patient-attributable costs of delivering an intensive, prophylactic swallowing therapy protocol via a new telepractice application "SwallowIT" as compared to clinician-directed FTF therapy and independent patient self-directed therapy. Patients (n = 79) with oropharyngeal HNC receiving definitive (C)RT were randomised to receive therapy via a: clinician-directed (n = 26), patient-directed (n = 27), or SwallowIT-assisted (n = 26) model of care. Data pertaining to health service costs (service time, consumables, therapy resources), patient-attributable costs (travel and wages) and patient-reported health-related quality of life (QoL) (AQoL-6D) were collected. SwallowIT provided a cost-efficient model of care when compared to the clinician-directed model, with significant cost savings to both the health service and to HNC consumers (total saving of $1901.10 AUD per patient; p < 0.001). The SwallowIT model also proved more cost-effective than the patient-directed model, yielding clinically significantly superior QoL at the end of (C)RT, for comparable costs. Overall, when compared to the alternate methods of service-delivery, SwallowIT provided a financially viable and cost-effective method for the delivery of intensive, prophylactic swallowing therapy to patients with HNC during (C)RT.

Entities:  

Keywords:  Cost-effectiveness; Deglutition; Deglutition disorders; Economic analysis; Head and neck cancer; Prophylactic swallowing therapy; Telepractice

Mesh:

Year:  2018        PMID: 30515560     DOI: 10.1007/s00455-018-9960-1

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  45 in total

Review 1.  Economic burden of head and neck cancer. A literature review.

Authors:  Jennifer M Lee; Marco Turini; Marc F Botteman; Jennifer M Stephens; Chris L Pashos
Journal:  Eur J Health Econ       Date:  2004-02

2.  A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.

Authors:  Valesca P Retèl; Lisette van der Molen; Lotte M G Steuten; Michiel W van den Brekel; Frans J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-11       Impact factor: 2.503

3.  Bending the cost curve in cancer care.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

4.  Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it.

Authors:  Katherine A Hutcheson; Mihir K Bhayani; Beth M Beadle; Kathryn A Gold; Eileen H Shinn; Stephen Y Lai; Jan Lewin
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-11       Impact factor: 6.223

5.  Medical oncology clinics through videoconferencing: an acceptable telehealth model for rural patients and health workers.

Authors:  S Sabesan; K Simcox; I Marr
Journal:  Intern Med J       Date:  2012-07       Impact factor: 2.048

6.  Survey of usual practice: dysphagia therapy in head and neck cancer patients.

Authors:  Gintas P Krisciunas; William Sokoloff; Katherine Stepas; Susan E Langmore
Journal:  Dysphagia       Date:  2012-03-29       Impact factor: 3.438

7.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  BMJ       Date:  2010-03-23

8.  A pilot trial of a speech pathology telehealth service for head and neck cancer patients.

Authors:  Clare L Burns; Elizabeth C Ward; Anne J Hill; Karen Malcolm; Lynell Bassett; Lizbeth M Kenny; Phillip Greenup
Journal:  J Telemed Telecare       Date:  2012-12-03       Impact factor: 6.184

9.  Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.

Authors:  Clare L Burns; Sanjeewa Kularatna; Elizabeth C Ward; Anne J Hill; Joshua Byrnes; Lizbeth M Kenny
Journal:  Head Neck       Date:  2017-09-30       Impact factor: 3.147

Review 10.  The economic burden of head and neck cancer: a systematic literature review.

Authors:  Erika Wissinger; Ingolf Griebsch; Juliane Lungershausen; Talia Foster; Chris L Pashos
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

View more
  2 in total

Review 1.  Telepractice and Dysphagia Management: The Era of COVID-19 and Beyond.

Authors:  Elizabeth C Ward; Madeline Raatz; Jeanne Marshall; Laurelie R Wishart; Clare L Burns
Journal:  Dysphagia       Date:  2022-04-15       Impact factor: 2.733

Review 2.  Telemedicine and Telementoring in Rhinology, Otology, and Laryngology: A Scoping Review.

Authors:  Angela Yang; Dayoung Kim; Peter H Hwang; Matt Lechner
Journal:  OTO Open       Date:  2022-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.